One study demonstrated that PD-1 expression by tumor cells is more frequent in advanced stage MF and Sezary syndrome (SS) than limited patch/plaque disease [9], which further emphasizes the need for further investigation of the interplay between folliculotropic MF and the clinical stage of MF with a larger dataset. The gene discussed is PDCD1; the disease is synovial sarcoma.